TF
ABBV icon

Trek Financial’s AbbVie ABBV Stock Holding History

Trek Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$794K Buy
3,156
+91
+3% +$19.6K 0.04% 282
2026
Q1 		$667K Sell
3,065
-5,834
-66% -$1.29M 0.04% 274
2025
Q4 		$2.03M Buy
8,899
+178
+2% +$40.5K 0.12% 168
2025
Q3 		$2.02M Buy
8,721
+1,112
+15% +$226K 0.12% 164
2025
Q2 		$1.41M Sell
7,609
-594
-7% -$110K 0.09% 178
2025
Q1 		$1.72M Buy
8,203
+955
+13% +$186K 0.12% 139
2024
Q4 		$1.29M Buy
7,248
+974
+16% +$179K 0.1% 167
2024
Q3 		$1.24M Buy
6,274
+847
+16% +$158K 0.09% 164
2024
Q2 		$931K Buy
5,427
+2,083
+62% +$345K 0.07% 174
2024
Q1 		$609K Sell
3,344
-2,947
-47% -$508K 0.05% 207
2023
Q4 		$975K Buy
6,291
+957
+18% +$140K 0.08% 128
2023
Q3 		$795K Sell
5,334
-368
-6% -$54K 0.07% 133
2023
Q2 		$768K Sell
5,702
-111
-2% -$16.3K 0.07% 128
2023
Q1 		$926K Buy
5,813
+1,724
+42% +$264K 0.09% 113
2022
Q4 		$661K Sell
4,089
-849
-17% -$130K 0.07% 127
2022
Q3 		$663K Sell
4,938
-515
-9% -$73.9K 0.07% 116
2022
Q2 		$835K Buy
5,453
+60
+1% +$9.17K 0.09% 97
2022
Q1 		$874K Sell
5,393
-439
-8% -$63.8K 0.08% 102
2021
Q4 		$790K Sell
5,832
-348
-6% -$41.1K 0.07% 80
2021
Q3 		$667K Buy
6,180
+567
+10% +$64.8K 0.07% 87
2021
Q2 		$632K Buy
+5,613
New +$632K 0.07% 89
2021
Q1 		– Sell
-4,141
Closed -$444K – 204
2020
Q4 		$444K Buy
+4,141
New +$398K 0.06% 102

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Trek Financial's ABBV Position: Q2 2026 in Review

Trek Financial increased its AbbVie (ABBV) stake by 3% in Q2 2026, buying an estimated $19.6K and bringing the position to 3,156 shares worth $794K. The position accounts for 0.04% of the portfolio, ranked #282.

Trek Financial first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.03M in Q4 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Trek Financial held 3,156 shares of AbbVie worth $794K as of Q2 2026.
  • Trek Financial bought 91 AbbVie shares in Q2 2026, an estimated $19.6K.
  • AbbVie made up 0.04% of Trek Financial's portfolio in Q2 2026, its #282 holding.
  • Trek Financial first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Trek Financial's AbbVie position peaked at $2.03M in Q4 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.